| scholarly article | Q13442814 |
| P50 | author | Eduardo Díaz-Rubio | Q41345398 |
| Silvia Veganzones | Q54297886 | ||
| Marta Vidaurreta | Q54297907 | ||
| Virginia De La Orden Garcia | Q80826450 | ||
| P2093 | author name string | M L Maestro | |
| J Cerdán | |||
| S Rafael | |||
| B Mediero | |||
| M Espantaleón | |||
| P2860 | cites work | Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas | Q24603535 |
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum | Q28262150 | ||
| Role of the p16 tumor suppressor gene in cancer | Q28265169 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer | Q33586020 | ||
| CpG island methylator phenotype and prognosis of colorectal cancer in Northeast China. | Q34177058 | ||
| Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. | Q34217637 | ||
| Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer | Q34358286 | ||
| MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features | Q34650716 | ||
| 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. | Q34777582 | ||
| Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype | Q34975498 | ||
| DNA methylation predicts recurrence from resected stage III proximal colon cancer | Q35051119 | ||
| Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803 | Q35729861 | ||
| CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies | Q35760749 | ||
| Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. | Q36213486 | ||
| Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing | Q36341102 | ||
| Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma | Q36529734 | ||
| Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. | Q36619262 | ||
| Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision. | Q36688767 | ||
| Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. | Q37091527 | ||
| Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location | Q37111201 | ||
| Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women | Q37170000 | ||
| CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer | Q37185561 | ||
| Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans | Q37269059 | ||
| An integrative CGH, MSI and candidate genes methylation analysis of colorectal tumors | Q37520573 | ||
| Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer. | Q37708015 | ||
| Pathways of colorectal carcinogenesis | Q38082332 | ||
| The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status | Q38417609 | ||
| Aberrant methylation of hMLH1 and p16INK4a in Tunisian patients with sporadic colorectal adenocarcinoma | Q39250757 | ||
| Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer | Q40822748 | ||
| Cancer of the microsatellite mutator phenotype. | Q41263775 | ||
| Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases | Q43735744 | ||
| CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer | Q44545555 | ||
| Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer | Q45141920 | ||
| Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers | Q51603737 | ||
| p16 gene methylation in colorectal cancer patients with long-term follow-up. | Q53177600 | ||
| Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. | Q53302100 | ||
| Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas | Q53373414 | ||
| DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers | Q53402717 | ||
| Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma | Q53603188 | ||
| Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer. | Q54745119 | ||
| CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. | Q54797906 | ||
| Adverse Prognostic Effect of Methylation in Colorectal Cancer Is Reversed by Microsatellite Instability | Q56589885 | ||
| RAF/RAS oncogenes and mismatch-repair status | Q57281056 | ||
| Genetics supersedes epigenetics in colon cancer phenotype | Q57977995 | ||
| Role of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal Cancer | Q58371725 | ||
| La inestabilidad de microsatélites predice un mejor pronóstico en los pacientes intervenidos de carcinoma colorrectal | Q58371729 | ||
| p16 Gene Methylation in Colorectal Tumors: Correlation with Clinicopathological Features and Prognostic Value | Q58371730 | ||
| Oncosuppressor methylation: A possible key role in colon metastatic progression | Q60170548 | ||
| Poor Survival Associated with theBRAFV600E Mutation in Microsatellite-Stable Colon Cancers | Q60673656 | ||
| Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status | Q61865595 | ||
| Association between CpG island methylation and microsatellite instability in colorectal cancer | Q73622839 | ||
| CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma | Q79988265 | ||
| APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer | Q80278776 | ||
| Colon cancer: it's CIN or CIMP | Q82175754 | ||
| Aberrant p16((INK4a)) methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity | Q84586357 | ||
| Molecular pathways and pathomorphology of colorectal cancers | Q84890225 | ||
| P433 | issue | 5 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 3853-3861 | |
| P577 | publication date | 2015-01-10 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors | |
| P478 | volume | 36 |
| Q26739706 | Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer |
| Q52802632 | Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review |
| Q33598672 | Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma |
| Q38637642 | The role of cell-free DNA in predicting colorectal cancer prognosis |
Search more.